Additional Remarks definition

Additional Remarks. REFERRING BROKER: RECIPIENT BROKER:

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedSchedule a Demo

Additional Remarks. (please provide any additional information that may help in processing your request)

Additional Remarks. (1) For U.S. Patent No. 5,366,977, entitled "Methods of Treating Cystic Fibrosis Using 8-Cyclopentyl-1,3-Dipropylxanthine or Xanthine Amino Congeners": exclusively for the treatment of cystic fibrosis and (2) For U.S. Patent Application Serial No. 08/343,714, filed November 22, 1994, entitled "A Method of Identifying CFTR-Binding Compounds Useful for Activating Chloride Conductance in Animal Cells": (i) exclusively for the treatment and diagnosis of cystic fibrosis in humans; (ii) exclusively for the class of compounds claimed for therapeutic and diagnostic uses for human diseases other than cystic fibrosis conditionally for a period of twenty-four (24) months; and (iii) nonexclusively for methods for identifying CFTR-binding compounds. This Patent License Agreement, hereinafter referred to as the "Agreement," consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), Appendix E (Benchmarks), and Appendix F (Commercial Development Plan). The Parties to this Agreement are:

Examples of Additional Remarks in a sentence

• CRADA Number (if applicable): Additional Remarks: This Patent License Agreement, hereinafter referred to as the "Agreement," consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (Patent or Patent Application), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), and Appendix B (Benchmarks).

• E.L. DISEASE - EA EMPLOYEE $ 1,000,000 (Mandatory in NH) If yes, describe under E.L. DISEASE - POLICY LIMIT $ 1,000,000 DESCRIPTION OF OPERATIONS below DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (▇▇▇▇▇ 101, Additional Remarks Schedule, may be attached if more space is required)The County of ▇▇▇▇▇, its officials, officers & employees are additional insured as respects General Liability & Automobile Liability; Primary & Non-Contriabutory - when required by written contract.

• Y ANE535009424 7/15/2024 7/15/2025 Limit Aggregate Retention $1,000,000 $1,000,000 $25,000 DESCRIPTION OF OPERATIONS / LOCATIONS / VEHICLES (▇▇▇▇▇ 101, Additional Remarks Schedule, may be attached if more space is required) City of Charlestown, IN Sanitary Sewer Board is additional insured as required by written contract with regards to General Liability, Umbrella Liability and professional liability coverage.

• COMPANY: Contents/Description Notes Desk Good Shape Credenza Nick - Minor Black Executive Chair Good Shape - New 2 Black Side Chairs New Silver Trash can New Aslcatel Telephone New 2 Artificial Plants Good Additional Remarks: Desk, credenza and artifical plants are property of Organ Transport Services.

• Certificates of Insurance:  ▇▇▇▇▇ 25 ‐ Certificate of Liability Insurance  ▇▇▇▇▇ 101 ‐ Additional Remarks  California Workers Compensation Certificates b.

More Definitions of Additional Remarks

Additional Remarks. The terms of this AGREEMENT shall be considered CONFIDENTIAL. Public Benefit(s): The principal benefit of this invention is its potential to treat diseases of hormonal or endocrine tissues. This exclusive patent license agreement (hereinafter referred to as the ("AGREEMENT"), made effective the first date upon which all the Parties have subscribed their signatures hereunto ("EFFECTIVE DATE"), consists of this Cover Page, an attached AGREEMENT, a Signature Page, Appendix A (List of Patent(s) and/or Patent Application(s)), Appendix B (LICENSED FIELDS-OF-USE and LICENSED TERRITORY), Appendix C (Royalties), Appendix D (Modifications), Appendix E (BENCHMARKS), and Appendix F (COMMERCIAL DEVELOPMENT PLAN). The Parties to this AGREEMENT are:

Additional Remarks. This Patent License Agreement, hereinafter referred to as the "